Coherus BioSciences
CHRS
#8205
Rank
โ‚น23.39 B
Marketcap
โ‚น193.56
Share price
2.39%
Change (1 day)
89.04%
Change (1 year)

Coherus BioSciences (CHRS) Fails to deliver data

Key failure to deliver metrics for Coherus BioSciences :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Coherus BioSciences (CHRS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Coherus BioSciences (CHRS) - since 2014

Volume in USD (price x number of shares), data since 2014

Coherus BioSciences (CHRS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026โ‚น0.32 M-92.51%
2025โ‚น4.4 M-13.23%
2024โ‚น5.07 M-66.46%
2023โ‚น15.13 M203.14%
2022โ‚น4.99 M-3.35%
2021โ‚น5.16 M-85.14%
2020โ‚น34.75 M659.1%
2019โ‚น4.57 M-79.64%
2018โ‚น22.49 M-5.08%
2017โ‚น23.69 M25.31%
2016โ‚น18.91 M-5.73%
2015โ‚น20.06 M5426.91%
2014โ‚น0.36 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Amgen
AMGN
โ‚น0.20 Bโ‚น0.37 B๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น6.47 Mโ‚น21.79 M๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
N/Aโ‚น0.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
N/Aโ‚น0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA